EMA

EMA

The only online source for all FDA documentation, PharmaPendium also offers you access to the European Medicines Agency’s (EMA) European Public Assessment Reports (EPARs).

Covering approximately 80,000 pages of searchable documents for EMA approved drugs from 1995 to the present day, and more than 300 ac­tive ingredients approved for the European market - some not approved in US - PharmaPendium is the definitive source of drug information.

The EMA EPAR documents provide critical data on:

  • Efficacy
  • Indications and dosage
  • Safety
  • Pharmacokinetics
  • Pharmacology and mode of action
  • Preclinical and clinical toxicity (extracted from documents) Adverse effects (extracted from documents)
  • General product information Providing real insights into the differences between the USFDA and EMA decision making process, you can rest assured that you’re as informed as possible.

PharmaPendium. Make informed drug development decisions.

Interested? Contact us today to find out more about how PharmaPendium could benefit you.

Demo or Quote

Would you like to find out how Pharmapendium’s unique benefits support you and your colleagues? Contact us now